×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Matt Abernethy


Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerMar 04, 2026Gift-2,249-42,808Mar 05, 2026, 06:18 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerFeb 13, 2026Option/RSU Exercise-4,807-41,676Feb 17, 2026, 05:49 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerFeb 12, 2026Tax Payment (Shares)$123.101,151141,68838,079Feb 17, 2026, 05:49 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerFeb 12, 2026Option/RSU Exercise-2,133-39,230Feb 17, 2026, 05:49 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerFeb 13, 2026Tax Payment (Shares)$124.127,973989,60944,881Feb 17, 2026, 05:49 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerJan 31, 2026Tax Payment (Shares)$136.061,368186,13037,097Feb 03, 2026, 06:06 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerJan 31, 2026Option/RSU Exercise-2,437-38,465Feb 03, 2026, 06:06 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerFeb 13, 2025Option/RSU Exercise-4,807-37,016Feb 14, 2025, 06:00 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerFeb 13, 2025Sale$116.862,558298,92335,810Feb 14, 2025, 06:00 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerFeb 08, 2025Option/RSU Exercise-1,860-34,541Feb 12, 2025, 06:41 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerFeb 10, 2025Sale$118.27980115,90933,561Feb 12, 2025, 06:41 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerJan 31, 2025Option/RSU Exercise-2,436-33,964Feb 04, 2025, 05:31 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerJan 31, 2025Sale$152.871,283196,13632,681Feb 04, 2025, 05:31 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerAug 13, 2024Option/RSU Exercise$73.6014,1001,037,76045,628Aug 15, 2024, 05:12 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerAug 13, 2024Sale$150.3814,1002,120,34731,528Aug 15, 2024, 05:12 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerJul 16, 2024Option/RSU Exercise$73.6090066,24032,428Jul 18, 2024, 04:45 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerJul 16, 2024Sale$150.04900135,03731,528Jul 18, 2024, 04:45 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerMay 15, 2024Sale$140.2415,0002,103,60931,528May 16, 2024, 04:40 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerMay 14, 2024Option/RSU Exercise$73.6015,0001,104,00046,528May 16, 2024, 04:40 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerMay 14, 2024Sale$135.6615,0002,034,82731,528May 16, 2024, 04:40 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerMay 15, 2024Option/RSU Exercise$73.6015,0001,104,00046,528May 16, 2024, 04:40 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerFeb 13, 2024Sale$132.851,352179,61231,528Feb 15, 2024, 05:27 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerFeb 08, 2024Sale$134.21980131,52930,314Feb 08, 2024, 07:12 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerFeb 06, 2024Sale$142.191,280182,00029,434Feb 08, 2024, 07:12 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerJan 31, 2024Sale$140.721,283180,53928,284Feb 02, 2024, 07:00 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerAug 21, 2023Sale$107.392,132228,95827,131Aug 23, 2023, 07:58 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerFeb 06, 2023Sale$105.671,280135,25322,507Feb 08, 2023, 07:16 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerFeb 07, 2023Sale$102.4026,3282,696,10735,824Feb 08, 2023, 07:16 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerFeb 08, 2023Sale$104.19980102,11025,213Feb 08, 2023, 07:16 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerJan 31, 2023Sale$109.981,283141,10821,357Feb 02, 2023, 04:53 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerFeb 07, 2022Sale$80.793,310267,42819,325Feb 09, 2022, 06:51 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerFeb 08, 2022Sale$79.6598078,05820,204Feb 09, 2022, 06:51 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerDec 01, 2021Sale$82.591,645135,85216,349Dec 03, 2021, 05:02 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerFeb 08, 2021Sale$116.822,910339,94214,869Feb 09, 2021, 09:30 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerDec 01, 2020Sale$94.661,645155,72111,494Dec 02, 2020, 04:12 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerNov 12, 2020Sale$90.742,257204,81010,014Nov 16, 2020, 06:02 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerAug 05, 2020Sale$118.902,257268,3557,983Aug 07, 2020, 06:22 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerMay 07, 2020Option/RSU Exercise$73.6015,0001,104,00020,953May 11, 2020, 08:17 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerMay 07, 2020Sale$110.2115,0001,653,1355,953May 11, 2020, 08:17 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerApr 28, 2020Sale$102.491,741178,4355,953Apr 30, 2020, 04:25 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerApr 24, 2020Sale$99.521,934192,4677,694Apr 28, 2020, 08:32 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerFeb 07, 2020Sale$103.352,030209,8075,701Feb 11, 2020, 07:06 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerDec 02, 2019Sale$116.331,645191,3603,876Dec 04, 2019, 06:06 PM
NBIXNEUROCRINE BIOSCIENCES INCMatt AbernethyChief Financial OfficerDec 03, 2018Sale$90.001,178106,0201,947Dec 06, 2018, 05:54 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe